General MedicationsORALGeneric
OXCARBAZEPINE
OXCARBAZEPINE
Standard Dose
300MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview OXCARBAZEPINE is listed in Drugs@FDA under application 219241 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient OXCARBAZEPINE Form and strength TABLET, EXTENDED RELEASE;ORAL - 300MG Sponsor AUROBINDO PHARMA LTD Submission history Latest submission status date: 2025-04-30 00:00:00.
Structured Monograph
Clinical summary
Approval overview OXCARBAZEPINE is listed in Drugs@FDA under application 219241 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient OXCARBAZEPINE Form and strength TABLET, EXTENDED RELEASE;ORAL - 300MG Sponsor AUROBINDO PHARMA LTD Submission history Latest submission status date: 2025-04-30 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.